Selected research
Industry Growth & Trends
Global Endocrine Disruptor Testing Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Endocrine Disruptor Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Endocrine Disruptor Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Endocrine Disruptor Testing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Endocrine Disruptor Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Endocrine Disruptor Testing market include Charles River Laboratories, Labcorp, Eurofins Scientific, PerkinElmer, Intertek, Smithers, LAUS, Xenometrix and ToxStrategies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Endocrine Disruptor Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Endocrine Disruptor Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Endocrine Disruptor Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Endocrine Disruptor Testing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Endocrine Disruptor Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Endocrine Disruptor Testing Market by Company
Charles River Laboratories
Labcorp
Eurofins Scientific
PerkinElmer
Intertek
Smithers
LAUS
Xenometrix
ToxStrategies
Fera Science
Compliance Services International
Staphyt
Creative Proteomics
Creative Bioarray
Endocrine Disruptor Testing Segment by Type
In Vitro (Cell-based) Testing
In Vivo (Animal) Testing
In Silico (Computational) Modeling
Others
Endocrine Disruptor Testing Segment by Application
Environmental Monitoring
Food Safety
Cosmetics and Personal Care Products
Public Health and Disease Prevention
Others
Endocrine Disruptor Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrine Disruptor Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Endocrine Disruptor Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrine Disruptor Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Endocrine Disruptor Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- In Vitro (Cell-based) Testing
- In Vivo (Animal) Testing
- In Silico (Computational) Modeling
- Others
Applications
- Environmental Monitoring
- Food Safety
- Cosmetics and Personal Care Products
- Public Health and Disease Prevention
- Others
Companies covered
- Charles River Laboratories
- Labcorp
- Eurofins Scientific
- PerkinElmer
- Intertek
- Smithers
- LAUS
- Xenometrix
- ToxStrategies
- Fera Science
- Compliance Services International
- Staphyt
- Creative Proteomics
- Creative Bioarray
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Endocrine Disruptor Testing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Endocrine Disruptor Testing Market Size by Region (2021-2032)
- 1.4.1 Global Endocrine Disruptor Testing Market Size by Region (2021-2026)
- 1.4.2 Global Endocrine Disruptor Testing Market Size by Region (2027-2032)
- 1.5 Key Regions Endocrine Disruptor Testing Market Size (2021-2032)
- 1.5.1 North America Endocrine Disruptor Testing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Endocrine Disruptor Testing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Endocrine Disruptor Testing Market Size Growth Rate (2021-2032)
- 1.5.4 South America Endocrine Disruptor Testing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Endocrine Disruptor Testing Market Size Growth Rate (2021-2032)
2 Endocrine Disruptor Testing Market by Type
- 2.1 Type Introduction
- 2.1.1 In Vitro (Cell-based) Testing
- 2.1.2 In Vivo (Animal) Testing
- 2.1.3 In Silico (Computational) Modeling
- 2.1.4 Others
- 2.2 Global Endocrine Disruptor Testing Market Size by Type
- 2.2.1 Global Endocrine Disruptor Testing Market Size Overview by Type (2021-2032)
- 2.2.2 Global Endocrine Disruptor Testing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Endocrine Disruptor Testing Market Size Forecasted by Type (2027-2032)
- 2.3 Global Endocrine Disruptor Testing Market Size by Regions
- 2.3.1 North America Endocrine Disruptor Testing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Endocrine Disruptor Testing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Endocrine Disruptor Testing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Endocrine Disruptor Testing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Endocrine Disruptor Testing Market Size Breakdown by Type (2021-2026)
3 Endocrine Disruptor Testing Market by Application
- 3.1 Type Introduction
- 3.1.1 Environmental Monitoring
- 3.1.2 Food Safety
- 3.1.3 Cosmetics and Personal Care Products
- 3.1.4 Public Health and Disease Prevention
- 3.1.5 Others
- 3.2 Global Endocrine Disruptor Testing Market Size by Application
- 3.2.1 Global Endocrine Disruptor Testing Market Size Overview by Application (2021-2032)
- 3.2.2 Global Endocrine Disruptor Testing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Endocrine Disruptor Testing Market Size Forecasted by Application (2027-2032)
- 3.3 Global Endocrine Disruptor Testing Market Size by Regions
- 3.3.1 North America Endocrine Disruptor Testing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Endocrine Disruptor Testing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Endocrine Disruptor Testing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Endocrine Disruptor Testing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Endocrine Disruptor Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Endocrine Disruptor Testing Industry Trends
- 4.2 Endocrine Disruptor Testing Industry Drivers
- 4.3 Endocrine Disruptor Testing Industry Opportunities and Challenges
- 4.4 Endocrine Disruptor Testing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Endocrine Disruptor Testing Revenue (2021-2026)
- 5.2 Global Endocrine Disruptor Testing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Endocrine Disruptor Testing Key Company Headquarters & Area Served
- 5.4 Global Endocrine Disruptor Testing Company, Product Type & Application
- 5.5 Global Endocrine Disruptor Testing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Endocrine Disruptor Testing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Endocrine Disruptor Testing Players Market Share by Revenue in 2025
- 5.6.3 2025 Endocrine Disruptor Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Charles River Laboratories
- 6.1.1 Charles River Laboratories Company Information
- 6.1.2 Charles River Laboratories Business Overview
- 6.1.3 Charles River Laboratories Endocrine Disruptor Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Charles River Laboratories Endocrine Disruptor Testing Product Portfolio
- 6.1.5 Charles River Laboratories Recent Developments
- 6.2 Labcorp
- 6.2.1 Labcorp Company Information
- 6.2.2 Labcorp Business Overview
- 6.2.3 Labcorp Endocrine Disruptor Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Labcorp Endocrine Disruptor Testing Product Portfolio
- 6.2.5 Labcorp Recent Developments
- 6.3 Eurofins Scientific
- 6.3.1 Eurofins Scientific Company Information
- 6.3.2 Eurofins Scientific Business Overview
- 6.3.3 Eurofins Scientific Endocrine Disruptor Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Eurofins Scientific Endocrine Disruptor Testing Product Portfolio
- 6.3.5 Eurofins Scientific Recent Developments
- 6.4 PerkinElmer
- 6.4.1 PerkinElmer Company Information
- 6.4.2 PerkinElmer Business Overview
- 6.4.3 PerkinElmer Endocrine Disruptor Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 PerkinElmer Endocrine Disruptor Testing Product Portfolio
- 6.4.5 PerkinElmer Recent Developments
- 6.5 Intertek
- 6.5.1 Intertek Company Information
- 6.5.2 Intertek Business Overview
- 6.5.3 Intertek Endocrine Disruptor Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Intertek Endocrine Disruptor Testing Product Portfolio
- 6.5.5 Intertek Recent Developments
- 6.6 Smithers
- 6.6.1 Smithers Company Information
- 6.6.2 Smithers Business Overview
- 6.6.3 Smithers Endocrine Disruptor Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Smithers Endocrine Disruptor Testing Product Portfolio
- 6.6.5 Smithers Recent Developments
- 6.7 LAUS
- 6.7.1 LAUS Company Information
- 6.7.2 LAUS Business Overview
- 6.7.3 LAUS Endocrine Disruptor Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 LAUS Endocrine Disruptor Testing Product Portfolio
- 6.7.5 LAUS Recent Developments
- 6.8 Xenometrix
- 6.8.1 Xenometrix Company Information
- 6.8.2 Xenometrix Business Overview
- 6.8.3 Xenometrix Endocrine Disruptor Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Xenometrix Endocrine Disruptor Testing Product Portfolio
- 6.8.5 Xenometrix Recent Developments
- 6.9 ToxStrategies
- 6.9.1 ToxStrategies Company Information
- 6.9.2 ToxStrategies Business Overview
- 6.9.3 ToxStrategies Endocrine Disruptor Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 ToxStrategies Endocrine Disruptor Testing Product Portfolio
- 6.9.5 ToxStrategies Recent Developments
- 6.10 Fera Science
- 6.10.1 Fera Science Company Information
- 6.10.2 Fera Science Business Overview
- 6.10.3 Fera Science Endocrine Disruptor Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Fera Science Endocrine Disruptor Testing Product Portfolio
- 6.10.5 Fera Science Recent Developments
- 6.11 Compliance Services International
- 6.11.1 Compliance Services International Company Information
- 6.11.2 Compliance Services International Business Overview
- 6.11.3 Compliance Services International Endocrine Disruptor Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Compliance Services International Endocrine Disruptor Testing Product Portfolio
- 6.11.5 Compliance Services International Recent Developments
- 6.12 Staphyt
- 6.12.1 Staphyt Company Information
- 6.12.2 Staphyt Business Overview
- 6.12.3 Staphyt Endocrine Disruptor Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Staphyt Endocrine Disruptor Testing Product Portfolio
- 6.12.5 Staphyt Recent Developments
- 6.13 Creative Proteomics
- 6.13.1 Creative Proteomics Company Information
- 6.13.2 Creative Proteomics Business Overview
- 6.13.3 Creative Proteomics Endocrine Disruptor Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Creative Proteomics Endocrine Disruptor Testing Product Portfolio
- 6.13.5 Creative Proteomics Recent Developments
- 6.14 Creative Bioarray
- 6.14.1 Creative Bioarray Company Information
- 6.14.2 Creative Bioarray Business Overview
- 6.14.3 Creative Bioarray Endocrine Disruptor Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Creative Bioarray Endocrine Disruptor Testing Product Portfolio
- 6.14.5 Creative Bioarray Recent Developments
7 North America
- 7.1 North America Endocrine Disruptor Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Endocrine Disruptor Testing Market Size by Country (2021-2026)
- 7.3 North America Endocrine Disruptor Testing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Endocrine Disruptor Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Endocrine Disruptor Testing Market Size by Country (2021-2026)
- 8.3 Europe Endocrine Disruptor Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Endocrine Disruptor Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Endocrine Disruptor Testing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Endocrine Disruptor Testing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Endocrine Disruptor Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Endocrine Disruptor Testing Market Size by Country (2021-2026)
- 10.3 South America Endocrine Disruptor Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Endocrine Disruptor Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Endocrine Disruptor Testing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Endocrine Disruptor Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst